Obstetrics & Gynecology Doctors in El Monte, CA Accepting Medicare

7 Obstetrics & Gynecology doctors found. Showing 1 - 7

Rose Wong, Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 10953 Ramona Blvd, El Monte, CA 91731 Phone: 626-579-8463

Ms. Silvia Diaz, Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 10953 Ramona Blvd, El Monte, CA 91731 Phone: 626-579-8463

Dr. Alonzo Fields, Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 10953 Ramona Blvd, El Monte, CA 91731 Phone: 626-579-8463

Julius C Kpaduwa, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 11036 Valley Mall, El Monte, CA 91731 Phone: 626-575-8342    Fax: 626-575-1237

Anne Quach Lam, NURSE PRACTITIONER Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 11017 Valley Mall, El Monte, CA 91731 Phone: 626-575-8342    Fax: 626-575-1237

Dr. Raymond Anthony Barajas, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3560 Santa Anita Ave, Ste H, El Monte, CA 91731 Phone: 626-579-9595    Fax: 626-579-3851

Gloria Haro, Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 10953 Ramona Blvd, El Monte, CA 91731 Phone: 626-579-8463

News Archive

Study identifies probable cause of Alzheimer's disease

Ground-breaking new Curtin University-led research has discovered a likely cause of Alzheimer's disease, in a significant finding that offers potential new prevention and treatment opportunities for Australia's second-leading cause of death.

XECAN's RFID Oncology Solution integrated with ThingMagic Astra UHF Reader

Trimble announced today that m, a leading provider of RFID patient safety solutions, has integrated the ThingMagic Astra UHF Reader into its RFID Oncology Solution. The XECAN solution enhances the patient experience and significantly assists in the goal of eliminating treatment errors allowing healthcare organizations to offer a safer and more inviting medical experience.

Enzalutamide has added benefit for men with castration-resistant prostate cancer at high risk of metastasis

In 2018 and 2019, the German Institute for Quality and Efficiency in Health Care already investigated whether the drug enzalutamide has an advantage in comparison with the appropriate comparator therapy, i.e. in comparison with watchful waiting while maintaining ongoing conventional androgen deprivation therapy (ADT), for adult men with high-risk non-metastatic castration-resistant prostate cancer.

Australian doctors are well connected to information technology in their practices

Australian Medical Association (AMA) President, Dr Mukesh Haikerwal, said this week that doctors are well connected to information technology in their practices, with over 90 per cent of GPs using electronic prescribing and communications systems.

Read more Medical News

› Verified 1 days ago